| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 139,504 | 115,954 | 107,417 | 167,079 | | Cost of Revenue | 88,373 | 68,789 | 74,249 | 97,410 | | | Gross Profit | 51,131 | 47,165 | 33,168 | 69,669 | | | Operating Expenses | | Research Development | 41,455 | 36,315 | 38,794 | 37,247 | | Selling General and Administrative | 30,662 | 25,435 | 29,755 | 30,879 | | Non Recurring |
-
|
-
| 686,634 | 344,648 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (20,986) | (14,585) | (722,015) | (343,105) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 83,946 | 1,425 | 609 | (4,150) | | Earnings Before Interest And Taxes | 62,960 | (13,160) | (721,406) | (347,255) | | Interest Expense | 11 | 19 | 13 | 14 | | Income Before Tax | 62,949 | (13,179) | (721,419) | (347,269) | | Income Tax Expense | 2,409 | 942 | (682) | (2,010) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 60,540 | (14,121) | (720,737) | (345,259) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 60,540 | (14,121) | (720,737) | (345,259) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $60,540 | ($14,121) | ($720,737) | ($345,259) |
|
0.02% Nasdaq 0.00%
Income Statement
